【正文】 eally want you to travel by ‘人類體能 的供應(yīng)商 的字樣，盡管它大概并非真的希望你用人力車代步。Now the firm has decided that its rulesbased culture is too inflexible to cope with thechallenges of globalisation and technological change，如今，沃爾瑪已經(jīng)認(rèn)識(shí)到其以規(guī)則為基礎(chǔ)的公司文化過(guò)于死板，無(wú)法應(yīng)對(duì)全球化和科技變革所帶來(lái)的挑戰(zhàn)。AS WALMART grew into the world s largest retailer, its staff were subjected to a long list ofdos and don ts covering every aspect of their ，其員工在工作的各方各面都受到了一大堆規(guī)則的限制。PepsiCo has started preaching a creed of performance with ： 目的性績(jī)效。Commissioned by Dov Seidman, boss of LRN, a firm that advises on corporate culture, andauthor of How ，LRN的老板、同時(shí)也是《怎么做到的?》a book arguing that the way firms do business matters as much as what they do, andconducted by the Boston Research Group, the National Governance, Culture and LeadershipAssessment is based on a survey of thousands of American employees, from every rung ofthe corporate ?塞德曼委托波士頓研究集團(tuán)進(jìn)行這項(xiàng) 國(guó)家治理、文化和領(lǐng)導(dǎo)能力評(píng)估 的研究，該研究是以對(duì)來(lái)自公司各個(gè)級(jí)別的數(shù)千位美國(guó)雇員的調(diào)查為基礎(chǔ)的。The study found evidence that such differences ，證明這些公司文化之間的差異事關(guān)重大。More than 90% of employees in selfgoverning firms, and twothirds in the informedacquiescence category, agreed that good ideas are readily adopted by my %的員工承認(rèn) 絕妙的想法很容易會(huì)被公司采納，選擇性順從型公司中也有三分之二的員工這樣認(rèn)為。Some 27% of bosses believe their employees are inspired by their %的老板認(rèn)為自己公司的員工能夠被公司所激勵(lì)。二．A big, bad business點(diǎn)肥成金不現(xiàn)實(shí)Medical firms struggle to profit from weightloss treatments制藥公司試圖從減肥治療中獲利OBESITY is an epidemic to some and an opportunity to ，對(duì)別的一些人來(lái)說(shuō)則是機(jī)遇。A mittee advising America s Food and Drug Administration remended that itapprove Vivus s diet drug, ，Vivus制藥公司朝著這個(gè)目標(biāo)前進(jìn)了一步。Pharmaceutical and medicaldevice panies are quite good at treating the conditions thate with 。Bariatric surgery can lead to weight loss in the long can make money fromall bariatric procedures, including gastric bypasses , but the gastric band is a rareexample of an opportunity for devicemakers to profit from weight 。Allergan has captured about 70% of the worldwide market for gastric bands and balloons, 可銳教育官網(wǎng)butsales are now %，但是如今銷量卻有所下降。In January David Pyott, Allergan s chief executive, said he would scrap an effort to marketthe band for ，Allergan公司首席執(zhí)行官David Pyott說(shuō)，他將放棄在年輕人束帶市場(chǎng)的努力。It has been 13 years since the FDA approved a prescription diet 。However, the agency may yet reject the 。For now, it is more profitable to treat fat patients than to try to make them ，治療肥胖患者還是要比讓他們減肥更有利可圖。It is also notable because it appears to be part of a broader attempt by the FTC to craft anew privacy framework to deal with the swift rise of social networks in ，那就是創(chuàng)建一個(gè)新的隱私框架以應(yīng)對(duì)美國(guó)快速攀升的社交網(wǎng)用戶。To clear the way for its blockbuster flotation, the firm first needs to resolve its privacytussles with regulators in America and ，臉譜網(wǎng)必須首先解決與美國(guó)和歐洲協(xié)調(diào)員關(guān)于用戶隱私的爭(zhēng)端，因此這周它公開(kāi)了商談意向。The settlement does not constitute an admission by Facebook that it has broken the 。Then he confessed that it could still do better and said he had hired two new chief ，他承認(rèn)確實(shí)有一些地方需要改進(jìn)，并說(shuō)明他已經(jīng)雇用了兩名新的 首席隱私官。There is a clear pattern 。可銳教育官網(wǎng)But outrage over Facebook s behaviour could spur Congress into action it willcertainly not be lost on regulators in Europe who are scrutinising the social network sprivacy record ，而正在審閱該社交網(wǎng)隱私記錄的歐洲協(xié)調(diào)員們也必然會(huì)給予這些不滿的呼聲以相應(yīng)的重視。In all, blockbusters with a bined $170 billion in annual sales will go offpatent by ，多種 重磅炸彈 藥物的專利都將失效。But generics makers may face delays getting their cheaper versions to ，非專利制藥企業(yè)卻發(fā)現(xiàn)仿制藥上市一拖再拖。Another tactic is payfordelay , in which a drugmaker facing a legal challenge to itspatent pays its wouldbe petitor to put off introducing its cheaper 有償延遲 協(xié)議，也就是說(shuō)在專利訴訟時(shí)，制藥企業(yè)會(huì)付給未來(lái)競(jìng)爭(zhēng)對(duì)手一筆錢，以延遲價(jià)錢更低的仿制藥進(jìn)入市場(chǎng)。To encourage generics makers to challenge patents on drugs, and introduce cheapercopies，為了鼓勵(lì)非專利制藥企業(yè)挑戰(zhàn)藥品專利、生產(chǎn)價(jià)錢更低的仿制藥，an American law passed in 1984 says that the first one to do so will get a 180day exclusivityperiod，美國(guó)于1984年通過(guò)一項(xiàng)法案，其中提到 第一個(gè)挑戰(zhàn)成功的仿制藥企能獲得180天市場(chǎng)獨(dú)占期，in which no other generics maker can sell versions of the drug in question, as Ranbaxysupposedly won with ，就像蘭伯西獲得立普妥仿制藥的生產(chǎn)權(quán)一樣。So Ranbaxy faces not one, but two ，蘭伯西的對(duì)手是兩個(gè)，而非一個(gè)。All this may raise Pfizer s sales by nearly $500m in the first half of 2012 pared with whatthey would otherwise have been, says Tim Anderson of BernsteinResearch, with revenuesthen falling after the 180 days are Anderson認(rèn)為，所有這些舉措將使得輝瑞2012年上半年的銷售額比不采取措施時(shí)增加近5億美元，總收入在180天市場(chǎng)獨(dú)占期后會(huì)下降。The biggest worry is that Pfizer s strategy, if copied, will make the 180day exclusivityperiod worth far less, and thus discourage generics firms from challenging patents in thefirst ，如若輝瑞的做法被仿制，那么180天專有期的價(jià)值會(huì)縮水，而仿制藥公司可銳教育官網(wǎng)挑戰(zhàn)專利的動(dòng)力也會(huì)在初期被抑制。要醫(yī)治病人，人們必須結(jié)合藥物試驗(yàn)采集數(shù)據(jù)。他們也對(duì)另外31名病人的基因組中含有基因的那些區(qū)域進(jìn)行了測(cè)序，并對(duì)其他240 名病人的這些部分做了部分測(cè)序。這些試驗(yàn)證實(shí)來(lái)曲唑是這類乳腺癌的標(biāo)準(zhǔn)治療方法，但它對(duì)每個(gè)病人的療效并不一樣。還有MAP3K1和MAP2K4，它們都能促進(jìn)細(xì)胞生長(zhǎng)。與此相反，這一藥物對(duì)腫瘤中MAP3K1或MAP2K4有變化的病人的療效高于平均水平。就雌激素受體陽(yáng)性乳腺癌來(lái)說(shuō)，基因分析還無(wú)法肯定地告訴我們，哪種藥物對(duì)某個(gè)病人療效最佳。自從1958年第一個(gè)永久起搏器被植入后，可植入醫(yī)療設(shè)備的制造商就在不斷嘗試為其產(chǎn)品提供電能的各種方法。應(yīng)用在心臟病和神經(jīng)源性疾病的移植設(shè)備中，一般能夠提供7年到10年的使用時(shí)間。Many other ideas have been tried down the kinetic energy of the human body, forexample, has long been harnessed to power watches, and should also be enough to keep apacemaker differences between the body and the ambient air meanthat thermoelectric couples can generate useful quantities of properly tuned devicecould capture background radiofrequency energy and rectify it into small amounts ofusable 。Although all these ideas have been shown to work in theoretical tests on lab benches, theyall suffer from the same handicap: intermittent patients, forinstance, generate little kinetic in a warm room reduces the poweravailable from radio waves are mon but not areserious drawbacks for an IMD that may be responsible for keeping someone ，但是他們都有一個(gè)同樣的缺陷：間歇運(yùn)行。這些問(wèn)題對(duì)于維持生命的可移植醫(yī)療設(shè)備來(lái)說(shuō)都是十分嚴(yán)重的缺陷。一個(gè)糖分供能的設(shè)備因此能夠取得持續(xù)供給的能量并且?guī)缀蹩梢栽谌魏挝恢眠M(jìn)行移植。Dr Singhal has implanted prototype devices into live with a fuel cell about thesize of a penny, the bionic bugs were able to generate over 20 microwatts during a twoweek 。這會(huì)使得Singhal博士的設(shè)備在移植后的幾個(gè)月內(nèi)便無(wú)法使用